Related Experiment Video
Updated: Oct 11, 2025

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
YTHDC1-mediated VPS25 regulates cell cycle by targeting JAK-STAT signaling in human glioma cells
Xiaolong Zhu1,2,3, Hui Yang1,2,3, Mengying Zhang1,2,3
1Central Laboratory, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, People's Republic of China.
Background:
Glioma is a common type of malignant brain tumor with a high mortality and relapse rate. The endosomal sorting complex required for transport (ESCRT) has been reported to be involved in tumorigenesis. However, the molecular mechanisms have not been clarified.
Methods:
Bioinformatics was used to screen the ESCRT subunits highly expressed in glioma tissues from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. The function of the ESCRT subunits in glioma cells was examined in vitro. Transcriptome sequencing analyzed the target genes and signaling pathways affected by the ESCRT subunit. Finally, the relationship between m6A (N6-methyladenosine) modification and high expression of the ESCRT subunit was studied.
Results:
VPS25 was upregulated in glioma tissues, which was correlated with poor prognosis in glioma patients. Furthermore, VPS25 knockdown inhibited the proliferation, blocked the cell cycle, and promoted apoptosis in glioma cells. Meanwhile, VPS25 induced a G0/G1 phase arrest of the cell cycle in glioma cells by directly mediating p21, CDK2, and cyclin E expression, and JAK-signal transducer and activator of transcription (STAT) activation. Finally, YTHDC1 inhibited glioma proliferation by reducing the expression of VPS25.
Conclusion:
These results suggest that VPS25 is a promising prognostic indicator and a potential therapeutic target for glioma.
Insights
VPS25, a component of the endosomal sorting complex required for transport (ESCRT), is highly expressed in glioma and linked to poor prognosis. Inhibiting VPS25 suppresses glioma cell growth, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Glioma is a prevalent malignant brain tumor with significant mortality and recurrence rates.
- The endosomal sorting complex required for transport (ESCRT) pathway is implicated in tumorigenesis, but its precise role in glioma remains unclear.
Purpose of the Study:
- To investigate the role of ESCRT subunits in glioma.
- To identify potential prognostic markers and therapeutic targets for glioma.
Main Methods:
- Bioinformatic analysis of TCGA and GEO databases to identify highly expressed ESCRT subunits in glioma.
- In vitro functional assays to assess the impact of ESCRT subunits on glioma cell behavior.
- Transcriptome sequencing to determine target genes and affected signaling pathways.
- Investigation of the relationship between N6-methyladenosine (m6A) modification and ESCRT subunit expression.
Main Results:
- VPS25 was found to be upregulated in glioma tissues, correlating with unfavorable patient prognosis.
- VPS25 knockdown inhibited glioma cell proliferation, induced cell cycle arrest at the G0/G1 phase, and promoted apoptosis.
- VPS25 influenced glioma cell cycle progression by regulating p21, CDK2, and cyclin E expression, and JAK-STAT signaling.
- YTHDC1 was observed to inhibit glioma proliferation by decreasing VPS25 expression.
Conclusions:
- VPS25 serves as a potential prognostic biomarker for glioma.
- VPS25 represents a promising therapeutic target for glioma treatment.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Related Concept Videos
The JAK-STAT Signaling Pathway
Inhibition of Cdk Activity
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...